The 10th National - Strategy Summit on Paragraph IV Litigation is dedicated to recent regulations and litigation in legal arguments for pharmaceuticals ip rights. the event is an opportunity to network with leading paragraph IV experts to ready yourself for future litigation.
Topics
- The outcomes of GSK v. Teva and Minerva Surgical v Hologic Inc into use as you prepare for upcoming Paragraph IV litigation
- The thoughts of Federal Circuit and PTAB Judges regarding to best practices when arguing a case related to pharmaceutical IP
- How President Bidens potential waiver in the fight against COVID-19 may affect the IP rights of pharmaceuticals and biologics going forward
- Abilities to protect company intellectual property overseas by examining current international regulations and court rulings
Who should Attend
Professionals from pharmaceutical and medical device companies with job titles such as:
- Associate General Counsel, IP
- Associate General Counsel, Litigation
- Senior Legal Counsel
- Patent Counsel
- Director, Intellectual Property
- Vice-President, Intellectual Property
- Head of Intellectual Property
- General Counsel
